The link below from Aetna on has COVID vaccine info as well as COVID billing and coding FAQs.
Aetna COVID Info
NERUCA along with MSNJ had the opportunity to talk with Governor Phil Murphy this evening and specifically discuss reimbursement issues regarding COVID testing and vaccinations. My thanks go out to Dr Markintosh Barthelemy, Dr Chirag Patel, and especially the Medical Society of New Jersey for their support and participation.
John Kulin, DO, FCUCM
The NJDOH is working closely with NERUCA to enroll NJ Urgent Care Centers that are capable of meeting the requirements for storage, handling, monitoring and administration of the COVID vaccines. At this time NJDOH feels it is likely that they will be able to ship the Moderna Vaccine, but even with this there is infrastructure and other factors that need to be in place.
Please email Nadine Blank email@example.com or myself firstname.lastname@example.org when you submit your application so we can coordinate with NJDOH.
Follow the links below to the most up to date information.
COVID Vaccines_Product information guide_12.04.20_CLEAN.pdf
John Kulin, DO FCUCM
From The Missourian
As of July 30, about 41% of Americans were avoiding medical care due to anxiety around COVID-19. Of that total, 12% were avoiding emergency or urgent care, and 32% were avoiding routine care, according to the Centers for Disease Control and Prevention.
Click here to read the full article.
From the Philadelphia Inquirer
Click here to read the article on logistical and structural issues that are delaying test results in Pennsylvania and New Jersey, with accounts from NERUCA board members Peter Hotz and Shaun Ginter.
Concerned about exposing patients and their families to COVID-19, doctors and other health professionals are expanding telehealth services, using a variety of audio and video technology to make connections.
Read the full article here
Article from NPR
The Centers for Disease Control and Prevention has asked states to prepare to distribute a potential coronavirus vaccine as soon as late October, according to a series of planning documents sent to public health officials last week.
ABBOTT'S FAST, $5, 15-MINUTE, EASY-TO-USE COVID-19 ANTIGEN TEST RECEIVES FDA EMERGENCY USE AUTHORIZATION; MOBILE APP DISPLAYS TEST RESULTS TO HELP OUR RETURN TO DAILY LIFE; RAMPING PRODUCTION TO 50 MILLION TESTS A MONTH
Read more here
- Abbott's BinaxNOW™ COVID-19 Ag Card is a rapid, reliable, highly portable, and affordable tool for detecting active coronavirus infections at massive scale
- Test delivers results in just 15 minutes with no instrumentation, using proven lateral flow technology with demonstrated sensitivity of 97.1% and specificity of 98.5% in clinical study
- Abbott to offer a no-charge complementary phone app, which allows people to display their BinaxNOW test results when asked by organizations where people gather, such as workplaces and schools
- Company will ship tens of millions of tests in September, ramping to 50 million tests a month at the beginning of October
From Managed Healthcare Executive. Link to Original
August 21, 2020
Peter Wehrwein, Briana Contreras
Senior Editor Peter Wehrwein speaks with Lou Ellen Horwitz, CEO of the Urgent Care Association, about how urgent care centers struggled to personal protective equipment and access to testing.
When Lou Ellen Horwitz saw tents going up in parking lots for COVID-19 testing centers, she had felt like raising her hand and saying, ‘Hey what about us?!’
“I am thinking, ‘We are right here. We don’t require an appointment. We have been walk-in since the day we were born. How did this get missed? So I think that is the tragedy as we see it,” Horwitz, CEO of the Urgent Care Association, said in a videointerview with Managed Healthcare Executive®
Horwitz said urgent care center had difficulty getting personal protective equipment (PPE) during the early part of the pandemic and that it is difficult now for urgent care centers, many of which are individually owned, to compete for the limited supply of rapid-test kits.
“Because there is a limit supply of tests and lot of people who want them, there is price fluctuation going on,” she said. “So if you’ve got a small center who is ready and it has an order in for $90,000 — that is not going to happen.”
Horwitz, whose association includes member that collectively own and operate 4,500 urgent care centers, say most of the urgent care centers are sending COVID-19 samples out to labs, which means a delay in getting a result: “We all know there is a timing issue there.”
Horwitz said during the early weeks of the pandemic when stay-at-home orders were in place and there was no testing, the number of patients seen at urgent care centers plummeted. “It was ghost town in urgent care for about two or three weeks.”
But then, she says, “patients started coming and coming and coming.” Because of the lack of PPE and testing, some centers had to turn people away, she said. “It was a rocky patch there as we were re-ramping up.”
Now the centers are seeing patients with twisted ankles, lacerations and normal run of problems seen at urgent care centers along added layer of patients with issues related to COVID-19.
“Everyone that I know, almost, is not overwhelmed but they are at peak — they are extremely busy.”
Horwitz said urgent care centers have had difficulty getting recognized as being part of the national response to COVID-19. “The space that we occupy in the continuum of health[care] is really, really important but kind of in the middle if you look at 100 years of traditional medicine.”
She said it was difficult “penetrating the national scene of health care,” and her members have tended to focus on issues at the state and local level.
“We have not spent a lot of time and energy trying to be heard on the national stage. That wasn’t what our members really needed. We aren’t spending hundreds of thousands of dollars every single year on a lobbyist.”
But Horwitz says urgent care’s place in the pecking order is changing because of patient demand.
“We already had such good relations with patients in the community. They are coming. And so the patients figured it out. So we are finally starting to get that clicking at the national level of, ‘we need to not put them on the third tier of the list for supplies’ because that is where the patients are going.”
The answer largely depends on whether Medicare and private health insurers will adequately cover virtual doctor visits once coronavirus outbreaks subside.
By Reed Abelson
Aug. 3, 2020
Telemedicine is having its moment. Over the last few months, millions of people have relied on video or telephone calls to talk to their doctors. But as the pandemic moves across the United States, and eventually recedes in some places, how long will the moment last?
While patients used virtual visits to avoid overcrowded and potentially infectious doctor’s offices or emergency rooms, many are returning to face-to-face appointments in cities where the threat has subsided.
And insurance payments for telehealth services, especially at full cost, may only be temporary.
Medicare’s coverage of a broad range of services is slated to end when the coronavirus no longer poses a public health emergency. Private insurers, which followed the federal government’s lead, could revert to paying doctors for virtual visits at a fraction of the cost for traditional visits, if anything at all.
Some of the nation’s biggest insurers, like UnitedHealthcare and Anthem, say they haven’t decided beyond September or October on whether to extend the policies they adopted that allowed for coverage in lieu of doctors’ visits during the coronavirus crisis.
“The concern everyone in the industry has is that reimbursement is in jeopardy,” said Dr. Mia Levy, the director of the cancer center at Rush University Medical Center in Chicago, which treated patients virtually during the height of the pandemic. “Because of telehealth, we were able to stay actively engaged with our patients,” she said.
While there is broad bipartisan support for telehealth coverage, Congress would have to pass specific legislation to make some of Medicare’s changes permanent.
“Reversing course would be a mistake,” said Seema Verma, the administrator for the federal program, which reimbursed doctors the same for virtual visits, including those over the telephone, as for in-person ones and relaxed rules about who can use telemedicine.
About nine million people under traditional Medicare used telemedicine services during the early months of the crisis. Early data does not show wide variations in use by race or ethnicity.
“It was really a no-brainer for us,” Ms. Verma said.
And spending on telemedicine services during the first peak of the coronavirus pandemic in the United States underscores the demand. In addition to federal spending through Medicare, nearly $4 billion was billed nationally for telehealth visits during March and April, compared to less than $60 million for the same two months of 2019, according to FAIR Health, a nonprofit group that analyzes private health insurance claims.
But to convince insurers they should continue paying for virtual care, doctors must demonstrate they can move beyond treating simple respiratory infections to caring for patients with chronic conditions like depression or diabetes. “From the perspective of managing the cost and quality, there’s a lot we don’t know about telemedicine,” said Dr. Rahul Rajkumar, the chief medical officer at Blue Cross Blue Shield of North Carolina.
BlueCross BlueShield of Tennessee says it is the first major insurer to make coverage of telehealth services permanent, but it has not yet determined how much it will eventually pay for the care. A few insurers, including Cigna and the Blue Cross plan in North Carolina, said they will continue to cover telehealth services at pandemic levels through the end of the year.
“We need to give providers time to get more comfortable,” said Dr. Scott Josephs, the chief medical officer for Cigna. To make remote medicine successful and worthwhile, doctors and medical groups need to invest in technology and train staff. “If they don’t have the time, they won’t make the investments,” he said.
The biggest hurdle to widespread adoption by both the government and insurers is the potential cost.
Lawmakers are reluctant to pass any bill that would significantly add to Medicare’s budget, with the government already spending a total of some $750 billion a year.
And private insurers see telemedicine as a way to save them money, said Sabrina Corlette, a research professor at Georgetown University, who helped author a recent report on how the companies responded to the pandemic. “Unless they are required to by the states or federal government, a lot of carriers will try to reimburse less for telehealth than an in-person visit,” she said.
For those at risk, telemedicine is particularly valuable. When a fever sent Susan Varak, 45, who has breast cancer, to the emergency room during the height of Chicago’s outbreak in April, she felt as if she were “walking into this war zone,” she said, because she was so terrified of catching the virus.
How can we help you lead a better, more fulfilling life at home during the pandemic?
She appreciates she still can see her oncologist remotely. “I don’t think it’s absolutely necessary to be face-to-face every couple of weeks,” she said.
Other patients like the convenience. David Collins, 67, didn’t have a choice when he had a 20-minute video visit in March to rule out a diagnosis of coronavirus. Like many practices during the pandemic, the Kelsey-Seybold Clinic, a large physician group in Houston, was not allowing most patients to come in.
“I loved it because it saved me a lot of time.” he said, adding “I’d much rather do that than drive across town and look for parking.”
But, a few months later, he didn’t hesitate to go to the clinic for his checkup. “There’s a little more hands-on required,” he explained, like getting a physical exam and having his blood pressure taken. Not everything can be done virtually, he said. “If you break your arm, an e-visit isn’t going to help you at all,” he said.
After seeing about 90 percent of its patients virtually, Kelsey-Seybold has “almost flip-flopped back,” said Dr. Donnie Aga, an internist who oversees telehealth for the group. Most patients seem to prefer an in-person appointment. “You could really see that people missed coming in,” he said.
With coronavirus cases now at epidemic levels in Texas, the clinic wants to shift to dividing visits to half virtual, half in person. “You’ve got to have a balance, for sure,” Dr. Aga said.
But how doctors and insurers can do that is still unknown.
“We need to see where the equilibrium ends up,” said Dr. Andrea Gelzer, the corporate chief medical officer for AmeriHealth Caritas, a Medicaid managed care company. “If the total number of visits far exceeds pre-Covid, I don’t think that’s sustainable,” she said. Additional visits that do not improve patients’ health will only result in higher costs.
Doctors have to be more discriminating about which patients to see remotely, said Rita Numerof, a health care consultant.
Telemedicine “was a solution to an immediate problem,” she said, and doctors did not have clear criteria about who should be seen, under what circumstances and for which conditions.
Many in Congress are already convinced that Medicare should continue the current coverage. “The Covid-19 pandemic has been a trial by fire, but the experience to date has made clear that the health care system is ready for broader access to telehealth on a permanent basis,” said Sen. Ron Wyden of Oregon, a Democrat who introduced legislation earlier this month.
On Thursday, Sen. Lamar Alexander of Tennessee, a Republican and chair of the Senate health committee, introduced the Telehealth Modernization Act, which would also make some changes permanent. The experience of the previous four months “will likely mean that hundreds of millions of physician-patient visits will be remote or online that were in-person before,” he said.
Since May, nearly 20 telemedicine bills have been brought to the House floor and about the same number in the Senate, said Miranda Franco, a senior policy adviser for the law firm Holland & Knight. She thinks legislation will be passed by the end of the year.
While some lawmakers favor permanently expanding Medicare payment for a broad range of telemedicine services, others are concerned about the technology’s cost and potential for fraud. “Now you’re talking about reimbursing services we haven’t reimbursed before,” Ms. Franco said.
Some patients say telemedicine is not a substitute for in-person care. Jorge Cueto, who is in his mid-20s, said a virtual visit is often an additional step before going to the doctor’s office for, say, a sore throat.
“It’s another fee, it’s another gating mechanism,” he said.
His parents, who are not fluent in English, prefer going to the doctor’s office because they find it easier to communicate in person, he said, and they have difficulty setting up video calls. “I don’t think they would be willing opt for telehealth if they weren’t required to do it,” Mr. Cueto said.
Others may not have access to a computer or smartphone to connect for video visits, and insurers are particularly wary of doctors charging for phone calls to follow up on lab results or tell someone to come to the office.
Even patients who have cellphones may not be able to afford a lengthy consultation, Dr. Levy said. She and her colleagues discovered some people stopped answering their phones at the end of the month because they had run out of minutes. “That was very eye-opening to us,” she said.
Some proponents argue the goal of telemedicine should not be to lower health care costs over all. One of its main benefits is improving patients’ access to care, said Dr. Ateev Mehrotra, a professor of health care policy at Harvard Medical School, adding that it would be foolish to expect savings if more people also get treatment. “Those don’t reconcile,” he said.
Insurers should evaluate whether telemedicine is more effective for treating conditions like depression than it is for, say, cancer. They could then make those distinctions in reimbursing for virtual visits, he said, just as they do for different prescription drugs.
“There should be no single telemedicine policy,” Dr. Mehrotra said.
Thank you to our Sponsors!
The North East Regional Urgent Care Association is a 501(c)6 non-profit organization. | Donate | Help | Sitemap
Contact us at: NERUCA 1 Giralda Farms, Suite 130, Madison NJ 07940